We are live on
!
Find out more
AbCellera Biologics
ABCL
ABCL
116 hedge funds and large institutions have $1.98B invested in AbCellera Biologics in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 25 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
115% more call options, than puts
Call options by funds: $65.4M | Put options by funds: $30.4M
92% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 25
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
1.99% more ownership
Funds ownership: 33.42% → 35.41% (+2%)
2% more funds holding
Funds holding: 114 → 116 (+2)
8% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 26
0% less capital invested
Capital invested by funds: $1.99B → $1.98B (-$8.58M)
Holders
116
Holders Change
+2
Holders Change %
+1.75%
% of All Funds
2.03%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.14%
New
28
Increased
48
Reduced
25
Closed
26
Calls
$65.4M
Puts
$30.4M
Net Calls
+$35M
Net Calls Change
+$25.4M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$113M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
+$34.1M |
| 3 |
Swedbank
Stockholm,
Sweden
|
+$16.9M |
| 4 |
Millennium Management
New York
|
+$13.8M |
| 5 |
DFO
Duquesne Family Office
New York
|
+$11.7M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$36.1M |
| 2 |
AWG
Alpha Wave Global
New York
|
-$29.4M |
| 3 |
LCM
Laurion Capital Management
New York
|
-$9.9M |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$9.29M |
| 5 |
Blackstone Inc
New York
|
-$7.7M |
